The Welsh Endocrine and Diabetes Society Autumn Meeting – 20th October 2022

Finalised programme for the Autumn meeting:

12:00 – 13:30Registration and lunch
13:30 – 13:45   Mike Atkinson: Morriston Hospital 
Current trend of Diabetic Ketoacidosis admission in Adults with Type 1 Diabetes in Wales
13:45 – 14:00Stephanie Hanna; Cardiff University School of Medicine
Intradermal injection of diabetes autoantigens results in recruitment of clonally expanded antigen specific T cells to skin and draining lymph nodes and facilitates monitoring of autoimmune response
14:00 – 14:15Helen Saunders; Hywel Dda Health Board
Role of Flash Glucose Monitoring in community diabetes care
14:15 – 14.30Romesh John; University Hospital of Wales  
Prevalence of thromboembolic events in 51 patients treated for Cushing’s Disease with Pituitary surgery at University Hospital of Wales over a 15-year period
14:30 – 14:45Richard Roberts; Morriston Hospital
Demographic differences in older adults with and without type 2 diabetes presenting to the Older Persons Assessment Service, Morriston Emergency Department
14:45 – 15:00Peter Taylor; University Hospital of Wales
Individuals on levothyroxine have higher HADS anxiety and depression scores than the general population and this is exacerbated by the Thr92Ala substitution in DIO2
15:00 – 15.15Megan Evans; University Hospital of Wales 
An audit to evaluate the care of women with Turner’s Syndrome at the University Hospital of Wales
15:15 – 15:30David Butler; Research Liaison Manager, Cardiff & Vale UHB
Research studies open to recruitment: an update
15.30 – 16.15   C O F F E E     B R E A K 
16:15 – 16.30Lynnette James – Pharmacist – Cardiff and Vale UHB 
Safety measures and resources for patients at risk of adrenal insufficiency
16.30 – 16.45Kyi Min Sann; Glan Clwyd Hospital
Uncommon presentation of adrenal insufficiency due to exotic infection
16:45 – 17:00Anna De Lloyd; Cardiff & Vale UHB
Conceived in the Chernobyl exclusion zone; a case discussion
17:00 – 17.15Giselle Sharaf; Royal Glamorgan Hospital
Fibroblast Growth Factor 23 – Mediated Hypophosphataemia: A Case Report
17.15 – 18.00   GUEST SPEAKER: Richard Quinton – Newcastle Upon Tyne Hospital
Is there any cardiovascular risk associated with testosterone treatment of hypogonadalmen? Lessons from the TestES study
18.00Meeting closed
20:30WEDS Meeting End

The organisers would like to thank the following companies for their sponsorship of the meeting:

No pharmaceutical companies have had any input into the agenda. Pharmaceutical companies
have sponsored the meeting through purchase of an exhibition stand. Acknowledgement of
sponsorship shown on the printed Programme, Abstract Booklet and on the WEDS Website.